0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cytomegalovirus (CMV) Diagnostic Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-33G4546
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Cytomegalovirus CMV Diagnostic Market Insights Forecast to 2028
BUY CHAPTERS

Global Cytomegalovirus (CMV) Diagnostic Market Research Report 2025

Code: QYRE-Auto-33G4546
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cytomegalovirus (CMV) Diagnostic Market Size

The global market for Cytomegalovirus (CMV) Diagnostic was valued at US$ 874 million in the year 2024 and is projected to reach a revised size of US$ 1298 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Cytomegalovirus (CMV) Diagnostic Market

Cytomegalovirus (CMV) Diagnostic Market

Cytomegalovirus belongs to the herpesviridae family and is a double-stranded DNA virus. This virus mainly causes asymptomatic infections or sometimes causes mild flu like symptoms; and later remains latent throughout life, which may reactivate. Thus, this virus can remain as a lifelong companion for some individuals and can be a silent killer for the others. Cytomegalovirus (CMV) infection is characterized by the development of such antibodies, which develop due to the infection of the virus that stays in an individual’s body throughout his life.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cytomegalovirus (CMV) Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytomegalovirus (CMV) Diagnostic.
The Cytomegalovirus (CMV) Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cytomegalovirus (CMV) Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytomegalovirus (CMV) Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cytomegalovirus (CMV) Diagnostic Market Report

Report Metric Details
Report Name Cytomegalovirus (CMV) Diagnostic Market
Accounted market size in year US$ 874 million
Forecasted market size in 2031 US$ 1298 million
CAGR 5.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott Laboratories, bioMérieux, BD Biosciences, Bio-Rad Laboratories, Roche, Bioneer Corp, Siemens Healthcare, Thermo Fisher Scientific, Realstar Group, Merck, Qiagen, Guangdong Hybribio, Sansure Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cytomegalovirus (CMV) Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cytomegalovirus (CMV) Diagnostic Market growing?

Ans: The Cytomegalovirus (CMV) Diagnostic Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Cytomegalovirus (CMV) Diagnostic Market size in 2031?

Ans: The Cytomegalovirus (CMV) Diagnostic Market size in 2031 will be US$ 1298 million.

Who are the main players in the Cytomegalovirus (CMV) Diagnostic Market report?

Ans: The main players in the Cytomegalovirus (CMV) Diagnostic Market are Abbott Laboratories, bioMérieux, BD Biosciences, Bio-Rad Laboratories, Roche, Bioneer Corp, Siemens Healthcare, Thermo Fisher Scientific, Realstar Group, Merck, Qiagen, Guangdong Hybribio, Sansure Biotech

What are the Application segmentation covered in the Cytomegalovirus (CMV) Diagnostic Market report?

Ans: The Applications covered in the Cytomegalovirus (CMV) Diagnostic Market report are Hospitals, Diagnostic Centers and Clinics, Others

What are the Type segmentation covered in the Cytomegalovirus (CMV) Diagnostic Market report?

Ans: The Types covered in the Cytomegalovirus (CMV) Diagnostic Market report are Blood, Urine

Recommended Reports

Infectious Disease Diagnostics

Viral Infection Therapeutics

Immunodiagnostics & Vaccines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood
1.2.3 Urine
1.3 Market by Application
1.3.1 Global Cytomegalovirus (CMV) Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic Centers and Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cytomegalovirus (CMV) Diagnostic Market Perspective (2020-2031)
2.2 Global Cytomegalovirus (CMV) Diagnostic Growth Trends by Region
2.2.1 Global Cytomegalovirus (CMV) Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cytomegalovirus (CMV) Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Cytomegalovirus (CMV) Diagnostic Market Dynamics
2.3.1 Cytomegalovirus (CMV) Diagnostic Industry Trends
2.3.2 Cytomegalovirus (CMV) Diagnostic Market Drivers
2.3.3 Cytomegalovirus (CMV) Diagnostic Market Challenges
2.3.4 Cytomegalovirus (CMV) Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cytomegalovirus (CMV) Diagnostic Players by Revenue
3.1.1 Global Top Cytomegalovirus (CMV) Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Cytomegalovirus (CMV) Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cytomegalovirus (CMV) Diagnostic Revenue
3.4 Global Cytomegalovirus (CMV) Diagnostic Market Concentration Ratio
3.4.1 Global Cytomegalovirus (CMV) Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytomegalovirus (CMV) Diagnostic Revenue in 2024
3.5 Global Key Players of Cytomegalovirus (CMV) Diagnostic Head office and Area Served
3.6 Global Key Players of Cytomegalovirus (CMV) Diagnostic, Product and Application
3.7 Global Key Players of Cytomegalovirus (CMV) Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cytomegalovirus (CMV) Diagnostic Breakdown Data by Type
4.1 Global Cytomegalovirus (CMV) Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Type (2026-2031)
5 Cytomegalovirus (CMV) Diagnostic Breakdown Data by Application
5.1 Global Cytomegalovirus (CMV) Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cytomegalovirus (CMV) Diagnostic Market Size (2020-2031)
6.2 North America Cytomegalovirus (CMV) Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025)
6.4 North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cytomegalovirus (CMV) Diagnostic Market Size (2020-2031)
7.2 Europe Cytomegalovirus (CMV) Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025)
7.4 Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cytomegalovirus (CMV) Diagnostic Market Size (2020-2031)
9.2 Latin America Cytomegalovirus (CMV) Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Cytomegalovirus (CMV) Diagnostic Introduction
11.1.4 Abbott Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.1.5 Abbott Laboratories Recent Development
11.2 bioMérieux
11.2.1 bioMérieux Company Details
11.2.2 bioMérieux Business Overview
11.2.3 bioMérieux Cytomegalovirus (CMV) Diagnostic Introduction
11.2.4 bioMérieux Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.2.5 bioMérieux Recent Development
11.3 BD Biosciences
11.3.1 BD Biosciences Company Details
11.3.2 BD Biosciences Business Overview
11.3.3 BD Biosciences Cytomegalovirus (CMV) Diagnostic Introduction
11.3.4 BD Biosciences Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.3.5 BD Biosciences Recent Development
11.4 Bio-Rad Laboratories
11.4.1 Bio-Rad Laboratories Company Details
11.4.2 Bio-Rad Laboratories Business Overview
11.4.3 Bio-Rad Laboratories Cytomegalovirus (CMV) Diagnostic Introduction
11.4.4 Bio-Rad Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.4.5 Bio-Rad Laboratories Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Cytomegalovirus (CMV) Diagnostic Introduction
11.5.4 Roche Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Bioneer Corp
11.6.1 Bioneer Corp Company Details
11.6.2 Bioneer Corp Business Overview
11.6.3 Bioneer Corp Cytomegalovirus (CMV) Diagnostic Introduction
11.6.4 Bioneer Corp Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.6.5 Bioneer Corp Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Cytomegalovirus (CMV) Diagnostic Introduction
11.7.4 Siemens Healthcare Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.7.5 Siemens Healthcare Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Cytomegalovirus (CMV) Diagnostic Introduction
11.8.4 Thermo Fisher Scientific Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Realstar Group
11.9.1 Realstar Group Company Details
11.9.2 Realstar Group Business Overview
11.9.3 Realstar Group Cytomegalovirus (CMV) Diagnostic Introduction
11.9.4 Realstar Group Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.9.5 Realstar Group Recent Development
11.10 Merck
11.10.1 Merck Company Details
11.10.2 Merck Business Overview
11.10.3 Merck Cytomegalovirus (CMV) Diagnostic Introduction
11.10.4 Merck Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.10.5 Merck Recent Development
11.11 Qiagen
11.11.1 Qiagen Company Details
11.11.2 Qiagen Business Overview
11.11.3 Qiagen Cytomegalovirus (CMV) Diagnostic Introduction
11.11.4 Qiagen Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.11.5 Qiagen Recent Development
11.12 Guangdong Hybribio
11.12.1 Guangdong Hybribio Company Details
11.12.2 Guangdong Hybribio Business Overview
11.12.3 Guangdong Hybribio Cytomegalovirus (CMV) Diagnostic Introduction
11.12.4 Guangdong Hybribio Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.12.5 Guangdong Hybribio Recent Development
11.13 Sansure Biotech
11.13.1 Sansure Biotech Company Details
11.13.2 Sansure Biotech Business Overview
11.13.3 Sansure Biotech Cytomegalovirus (CMV) Diagnostic Introduction
11.13.4 Sansure Biotech Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
11.13.5 Sansure Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Blood
 Table 3. Key Players of Urine
 Table 4. Global Cytomegalovirus (CMV) Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Cytomegalovirus (CMV) Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Cytomegalovirus (CMV) Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Cytomegalovirus (CMV) Diagnostic Market Share by Region (2020-2025)
 Table 8. Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Cytomegalovirus (CMV) Diagnostic Market Share by Region (2026-2031)
 Table 10. Cytomegalovirus (CMV) Diagnostic Market Trends
 Table 11. Cytomegalovirus (CMV) Diagnostic Market Drivers
 Table 12. Cytomegalovirus (CMV) Diagnostic Market Challenges
 Table 13. Cytomegalovirus (CMV) Diagnostic Market Restraints
 Table 14. Global Cytomegalovirus (CMV) Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Cytomegalovirus (CMV) Diagnostic Market Share by Players (2020-2025)
 Table 16. Global Top Cytomegalovirus (CMV) Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (CMV) Diagnostic as of 2024)
 Table 17. Ranking of Global Top Cytomegalovirus (CMV) Diagnostic Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Cytomegalovirus (CMV) Diagnostic Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Cytomegalovirus (CMV) Diagnostic, Headquarters and Area Served
 Table 20. Global Key Players of Cytomegalovirus (CMV) Diagnostic, Product and Application
 Table 21. Global Key Players of Cytomegalovirus (CMV) Diagnostic, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Cytomegalovirus (CMV) Diagnostic Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Type (2020-2025)
 Table 25. Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Type (2026-2031)
 Table 27. Global Cytomegalovirus (CMV) Diagnostic Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Application (2020-2025)
 Table 29. Global Cytomegalovirus (CMV) Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Cytomegalovirus (CMV) Diagnostic Revenue Market Share by Application (2026-2031)
 Table 31. North America Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Abbott Laboratories Company Details
 Table 47. Abbott Laboratories Business Overview
 Table 48. Abbott Laboratories Cytomegalovirus (CMV) Diagnostic Product
 Table 49. Abbott Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 50. Abbott Laboratories Recent Development
 Table 51. bioMérieux Company Details
 Table 52. bioMérieux Business Overview
 Table 53. bioMérieux Cytomegalovirus (CMV) Diagnostic Product
 Table 54. bioMérieux Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 55. bioMérieux Recent Development
 Table 56. BD Biosciences Company Details
 Table 57. BD Biosciences Business Overview
 Table 58. BD Biosciences Cytomegalovirus (CMV) Diagnostic Product
 Table 59. BD Biosciences Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 60. BD Biosciences Recent Development
 Table 61. Bio-Rad Laboratories Company Details
 Table 62. Bio-Rad Laboratories Business Overview
 Table 63. Bio-Rad Laboratories Cytomegalovirus (CMV) Diagnostic Product
 Table 64. Bio-Rad Laboratories Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 65. Bio-Rad Laboratories Recent Development
 Table 66. Roche Company Details
 Table 67. Roche Business Overview
 Table 68. Roche Cytomegalovirus (CMV) Diagnostic Product
 Table 69. Roche Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 70. Roche Recent Development
 Table 71. Bioneer Corp Company Details
 Table 72. Bioneer Corp Business Overview
 Table 73. Bioneer Corp Cytomegalovirus (CMV) Diagnostic Product
 Table 74. Bioneer Corp Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 75. Bioneer Corp Recent Development
 Table 76. Siemens Healthcare Company Details
 Table 77. Siemens Healthcare Business Overview
 Table 78. Siemens Healthcare Cytomegalovirus (CMV) Diagnostic Product
 Table 79. Siemens Healthcare Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 80. Siemens Healthcare Recent Development
 Table 81. Thermo Fisher Scientific Company Details
 Table 82. Thermo Fisher Scientific Business Overview
 Table 83. Thermo Fisher Scientific Cytomegalovirus (CMV) Diagnostic Product
 Table 84. Thermo Fisher Scientific Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 85. Thermo Fisher Scientific Recent Development
 Table 86. Realstar Group Company Details
 Table 87. Realstar Group Business Overview
 Table 88. Realstar Group Cytomegalovirus (CMV) Diagnostic Product
 Table 89. Realstar Group Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 90. Realstar Group Recent Development
 Table 91. Merck Company Details
 Table 92. Merck Business Overview
 Table 93. Merck Cytomegalovirus (CMV) Diagnostic Product
 Table 94. Merck Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 95. Merck Recent Development
 Table 96. Qiagen Company Details
 Table 97. Qiagen Business Overview
 Table 98. Qiagen Cytomegalovirus (CMV) Diagnostic Product
 Table 99. Qiagen Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 100. Qiagen Recent Development
 Table 101. Guangdong Hybribio Company Details
 Table 102. Guangdong Hybribio Business Overview
 Table 103. Guangdong Hybribio Cytomegalovirus (CMV) Diagnostic Product
 Table 104. Guangdong Hybribio Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 105. Guangdong Hybribio Recent Development
 Table 106. Sansure Biotech Company Details
 Table 107. Sansure Biotech Business Overview
 Table 108. Sansure Biotech Cytomegalovirus (CMV) Diagnostic Product
 Table 109. Sansure Biotech Revenue in Cytomegalovirus (CMV) Diagnostic Business (2020-2025) & (US$ Million)
 Table 110. Sansure Biotech Recent Development
 Table 111. Research Programs/Design for This Report
 Table 112. Key Data Information from Secondary Sources
 Table 113. Key Data Information from Primary Sources
 Table 114. Authors List of This Report


List of Figures
 Figure 1. Cytomegalovirus (CMV) Diagnostic Picture
 Figure 2. Global Cytomegalovirus (CMV) Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cytomegalovirus (CMV) Diagnostic Market Share by Type: 2024 VS 2031
 Figure 4. Blood Features
 Figure 5. Urine Features
 Figure 6. Global Cytomegalovirus (CMV) Diagnostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cytomegalovirus (CMV) Diagnostic Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Diagnostic Centers and Clinics Case Studies
 Figure 10. Others Case Studies
 Figure 11. Cytomegalovirus (CMV) Diagnostic Report Years Considered
 Figure 12. Global Cytomegalovirus (CMV) Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global Cytomegalovirus (CMV) Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cytomegalovirus (CMV) Diagnostic Market Share by Region: 2024 VS 2031
 Figure 15. Global Cytomegalovirus (CMV) Diagnostic Market Share by Players in 2024
 Figure 16. Global Top Cytomegalovirus (CMV) Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (CMV) Diagnostic as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by Cytomegalovirus (CMV) Diagnostic Revenue in 2024
 Figure 18. North America Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America Cytomegalovirus (CMV) Diagnostic Market Share by Country (2020-2031)
 Figure 20. United States Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Cytomegalovirus (CMV) Diagnostic Market Share by Country (2020-2031)
 Figure 24. Germany Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Cytomegalovirus (CMV) Diagnostic Market Share by Region (2020-2031)
 Figure 32. China Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Cytomegalovirus (CMV) Diagnostic Market Share by Country (2020-2031)
 Figure 40. Mexico Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Cytomegalovirus (CMV) Diagnostic Market Share by Country (2020-2031)
 Figure 44. Turkey Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE Cytomegalovirus (CMV) Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Abbott Laboratories Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 48. bioMérieux Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 49. BD Biosciences Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 51. Roche Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 52. Bioneer Corp Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 53. Siemens Healthcare Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 55. Realstar Group Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 56. Merck Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 57. Qiagen Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 58. Guangdong Hybribio Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 59. Sansure Biotech Revenue Growth Rate in Cytomegalovirus (CMV) Diagnostic Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart